ISPE 2022 Annual Meeting
Gaylord Palms Resort & Convention Center
Orlando, FL
October 30th – November 2nd, 2022

We are looking forward to seeing you at the 2022 ISPE Annual Meeting & Expo. This annual event will usher in a revitalized focus on excellence, modernization, and harmonization in pharmaceutical science and manufacturing.

FEATURED SPEAKER

Day 3 Concurrent Session: “Moving from Pharma 3.0 to 4.0 and Harnessing the Power of the Pharma 4.0™ “Vision.”
Tuesday, November 1st
10:45 am – 12:15 pm EST

Hear Scott Deckebach, MBA, Director in the Lachman Consultants’ Compliance Practice, discuss Quality 4.0 – Revolutionizing the Role of Quality and why quality organizations must make strategic shifts in process, approach, skills, and mindset, and redefine how data is used to achieve a quality mission sustainably, and efficiently.

Like many industries, the pharmaceutical industry, is being propelled forward by a digital tsunami – where a tidal wave of data will continue to transform and forge the future of the industry. Currently, in the Pharma 3.0 environment the approach for automation is in a process-centric environment. However, moving to Pharma 4.0™, a different approach in which the data life cycle is centralized, will lead to one that is data centric. This session discusses the current status and examples of practical transformational methodologies to achieving digitalized Pharma 4.0™ Operating Model-based organization.

VISIT WITH LACHMAN CONSULTANTS AT OUR ISPE 2022 WELCOME RECEPTIONS

Monday, October 31st
5 pm-6:45 pm EST

Expo Hall

Register Here

 

MEET WITH LACHMAN CONSULTANTS

The Lachman Consultant’s team is comprised of highly accomplished consultants who have a solid knowledge base, strong connections, and wisdom that can only come from decades of industry experience. Our practice groups collaborate extensively, ensuring that problems entrusted to us are addressed from all angles:

  • Pharmaceutical
  • Medical Device/Combination Products
  • Biotechnology/Biologics

Lachman Consultants offers a full portfolio of technology capabilities to deliver measurable results that prevent and resolve compliance problems and develop new products for regulatory submission and approval by FDA.

  • Regulatory
  • Compliance
  • Data Integrity
  • Analytical Services
  • Biomonitoring Support
  • Strategic Planning

Talk to Lachman Consultants’ SMEs and discover our unmatched depth of expertise in compliance, regulatory, and science and technology, and learn how you can

Experience. Excellence.™

Schedule a meeting with Lachman Consultants at ISPE 2022 Annual Meeting